Semaglutide

Semaglutide changed everything. Before Wegovy® and Ozempic® entered the conversation, medical weight management options were limited, inconsistent, and mostly disappointing. Now there's a GLP-1 receptor agonist with years of clinical data, FDA approval for weight management, and outcomes that reshaped the entire field.

What Semaglutide Is

Semaglutide is a GLP-1 receptor agonist — a synthetic analog of the naturally occurring incretin hormone glucagon-like peptide-1 that binds to GLP-1 receptors in the hypothalamus and gastrointestinal tract to suppress appetite, delay gastric emptying, enhance insulin secretion, and reduce caloric intake, resulting in sustained, clinically significant weight reduction.

The STEP clinical trial program — spanning multiple large-scale studies — demonstrated that semaglutide produces approximately 15% body weight reduction over 68 weeks. That data earned Wegovy® its FDA approval specifically for chronic weight management in 2021.

Semaglutide has more published long-term safety and efficacy data than any other GLP-1 medication. Maintenance Bar prescribes it with confidence backed by years of real-world outcomes. For patients who want the most established peptide option, semaglutide is the standard.

How Semaglutide Works at Maintenance Bar

01

Step 1: Medical Assessment

Megan Bedker ARNP reviews your complete health profile — medical history, medications, prior weight management attempts, and metabolic indicators. Maintenance Bar requires a thorough evaluation before prescribing. Semaglutide is a medical intervention, and we treat it as one.

Step 2: Dose Initiation and Titration. Semaglutide starts at 0.25mg weekly and increases gradually over 16-20 weeks to the target dose. This slow titration is essential.

Rushing the dose ramp causes the nausea and GI distress that makes patients quit. Maintenance Bar's protocol respects the biology.

Step 3: Progress Monitoring. Regular appointments at our Seattle clinic assess weight trajectory, appetite changes, side effects, and overall wellbeing. Your Maintenance Bar provider adjusts timing and dosing based on your individual response — not a rigid schedule that ignores how you're actually feeling.

Step 4: Aesthetic Preservation. Weight loss depletes facial fat pads. This volume loss — commonly called "Ozempic face" — creates hollowed cheeks, under-eye deepening, and premature aging.

Maintenance Bar integrates Sculptra biostimulation and volume restoration alongside your semaglutide protocol. We restore what weight loss takes.

What to Expect from Semaglutide at Maintenance Bar

Most patients notice reduced appetite within the first 1-2 weeks. The "food noise" — that constant mental loop of cravings and hunger signals — gets quieter. Maintenance Bar patients consistently describe this as the most life-changing aspect.

Visible weight loss typically begins by weeks 4-8. The STEP trials showed approximately 15% body weight loss over 68 weeks at maintenance dosing. Individual results at Maintenance Bar vary based on starting weight, dose tolerance, and lifestyle factors.

Semaglutide is a weekly subcutaneous injection. Most patients self-administer after initial training at our Seattle clinic. Common side effects include nausea, constipation, and decreased appetite — primarily during dose escalation phases.

Maintenance Bar's integrated approach means your aesthetic team monitors facial changes in real time. Proactive facial contouring treatments maintain volume and structure as weight comes off — so you look as good as you feel throughout the process.

Patients also report improvements in energy, metabolic markers, and mental clarity as weight decreases. Maintenance Bar tracks these non-scale victories because they matter just as much as the number on the scale.

Your provider at our Seattle clinic documents everything — photos, labs, dosing history. Maintenance Bar's records keep your weight management and aesthetic protocols perfectly synchronized.

Who Benefits from Semaglutide at Maintenance Bar

Semaglutide is ideal for patients who want the most established, extensively studied GLP-1 medication available. If a long clinical track record and years of real-world data matter to you, Maintenance Bar recommends semaglutide confidently.

Patients with medullary thyroid carcinoma history, MEN2 syndrome, or severe GI conditions should discuss alternatives with their provider. Maintenance Bar screens every patient before prescribing. Your safety is non-negotiable.

Semaglutide combines beautifully with facial contouring and Sculptra at Maintenance Bar. Proactive volume treatments prevent the facial hollowing that catches patients off guard at clinics without aesthetic integration.

If you're weighing semaglutide against tirzepatide, book a consultation at our Seattle clinic. Maintenance Bar's provider compares the clinical evidence side by side and matches you with the peptide that fits your biology.

Frequently Asked Questions

How is semaglutide different from tirzepatide?

Semaglutide activates GLP-1 receptors only. Tirzepatide activates both GIP and GLP-1 receptors.

Clinical trials show tirzepatide produces slightly greater average weight loss, but semaglutide has a longer track record with more published long-term data. Maintenance Bar offers both and recommends based on your specific medical profile.

What happens if I stop taking semaglutide?

Research shows weight regain is common after discontinuation — the body's appetite regulation returns to pre-treatment patterns. Maintenance Bar discusses long-term planning during your consultation. Options include ongoing maintenance dosing, dose reduction strategies, and lifestyle protocols that support sustained results.

Will semaglutide change my face?

It can. Significant weight loss reduces facial fat volume, creating a hollow or aged appearance. This is exactly why Maintenance Bar is the right place for peptide therapy.

Your weight loss provider and your aesthetic provider are the same team. We monitor facial changes and intervene with Sculptra or filler before volume loss becomes dramatic.

Can I switch from tirzepatide to semaglutide at Maintenance Bar?

Yes. Some patients prefer semaglutide's established track record or respond better to single-pathway GLP-1 activation. Your Maintenance Bar provider manages the transition seamlessly — adjusting dosing to maintain your progress.

What if I experience nausea on semaglutide?

Nausea is most common during dose escalation and typically resolves as your body adjusts. Maintenance Bar's titration protocol is deliberately slow to minimize this. Your provider can also adjust injection timing and recommend dietary strategies that reduce GI symptoms.

Start Semaglutide Treatment at Maintenance Bar in Seattle

Without aesthetic monitoring, significant weight loss can trade one frustration for another — a slimmer body alongside a face that suddenly looks older than you feel.